We made our hosts read (some of) Infinite Jest, the thousand-page novel by David Foster Wallace that turns 30 this month, to answer the question once and for all: Do we have to read this book? The ...

Microsoft CEO Satya Nadella and former UK Prime Minister Rishi Sunak at the World Economic Forum in Davos. (Screenshot via LinkedIn) Bicycles for the mind. … Information at your fingertips. … Managers ...

Raids are one of the best parts of Destiny 2, requiring teamwork and coordination to solve puzzles, find platforming routes, and, of course, shoot enemies. Shard of Acsension is a playable Destiny 2 ...

Is the universe infinite? It's one of the most profound questions we can ask, and here's the short answer: We don't know. While we have learned a great deal about the universe, a portion of the cosmos ...

Halo Infinite had one of the best-feeling sandboxes in franchise history. The movement, the gunplay, the physics: everything clicked. But great gameplay alone can’t carry a live-service shooter, and ...

Despite the odds being stacked against it and a rough launch, 'Halo Infinite' grew into its own good thing over time. Reading time 3 minutes On December 8, 2021, 343 Industries released Halo Infinite.

GameSpot may get a commission from retail offers. The time of Halo: Infinite is coming to a close. Microsoft and Halo Studios have revealed that the game's next major update, Operation: Infinite, will ...

Microsoft and Halo Studios are looking ahead to the future, but that future will not include new content for Halo Infinite. After four years, the latest installment of the Halo timeline appears poised ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please send the good word—or the bad—from your shop to Darren ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...